Abstract.
Magainins are a group of short peptides originally isolated from frog skin and thought to function as a natural defense mechanism against infection due to their antimicrobial properties. The engineered magainin analog peptide Myp30 was found to inhibit spore germination of the oomycete, Peronospora tabacina (Adam) in vitro, and the growth of a bacterial pathogen Erwinia carotovora subsp. carotovora (Jones). Transgenic tobacco (Nicotiana tabacum L.) plants expressing Myp30 were evaluated for resistance to these pathogens. The expression of the peptide only to an extracellular location resulted in significant reduction in sporulation and lesion size due to P. tabacina infection. A significant increase in resistance to the bacterial pathogen was also observed regardless of the targeting location of the peptide.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 7 August 2000 / Accepted: 27 September 2000
Rights and permissions
About this article
Cite this article
Li, Q., Lawrence, C., Xing, HY. et al. Enhanced disease resistance conferred by expression of an antimicrobial magainin analog in transgenic tobacco. Planta 212, 635–639 (2001). https://doi.org/10.1007/s004250000480
Issue Date:
DOI: https://doi.org/10.1007/s004250000480